Publications

George, DJ, and Moul, JW. "Docetaxel/capecitabine well tolerated but less effective than docetaxel/estramustine." Oncology Report, no. SPRING (March 1, 2005): 54-55.

Scholars@Duke

Lyman, GH, Berndt, ER, Kallich, JD, Erder, MH, Crown, WH, Long, SR, Lee, H, Song, X, and Finkelstein, SN. "The economic burden of anemia in cancer patients receiving chemotherapy." Value Health 8, no. 2 (March 2005): 149-156.

PMID
15804323
Full Text

Friedman, HS. "Radiation sensitizer shows promise in breast cancer patients with brain metastases." Oncology Report, no. SPRING (March 1, 2005): 14-16.

Scholars@Duke

George, DJ, and Moul, JW. "Combined GM-CSF/docetaxel beneficial against HR prostate cancer." Oncology Report, no. SPRING (March 1, 2005): 51-52.

Scholars@Duke

Shi, Q, Zhang, Z, Neumann, AS, Li, G, Spitz, MR, and Wei, Q. "Case-control analysis of thymidylate synthase polymorphisms and risk of lung cancer." Carcinogenesis 26, no. 3 (March 2005): 649-656.

PMID
15579479
Full Text

Friedman, HS. "'Encouraging news': Vaccine increases survival in phase I brain cancer trial." Oncology Report, no. SPRING (March 1, 2005): 13-14.

Scholars@Duke

George, DJ, and Moul, JW. "CA9 shown to predict response to IL-2 therapy for renal cell carcinoma." Oncology Report, no. SPRING (March 1, 2005): 59-60.

Scholars@Duke

Liu, Z, Calderon, JI, Zhang, Z, Sturgis, EM, Spitz, MR, and Wei, Q. "Polymorphisms of vitamin D receptor gene protect against the risk of head and neck cancer." Pharmacogenetics and genomics 15, no. 3 (March 2005): 159-165.

PMID
15861040
Full Text

Friedman, HS. "Promising results in overcoming temozolomide resistance." Oncology Report, no. SPRING (March 1, 2005): 12-13.

Scholars@Duke

Friedman, HS. "Adding temozolomide to radiation improves survival in patients with glioblastoma." Oncology Report, no. SPRING (March 1, 2005): 11-12.

Scholars@Duke

Pages